This is a Validated Antibody Database (VAD) review about human SLAMF7, based on 12 published articles (read how Labome selects the articles), using SLAMF7 antibody in all methods. It is aimed to help Labome visitors find the most suited SLAMF7 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
SLAMF7 synonym: 19A; CD319; CRACC; CS1; SLAM family member 7; 19A24 protein; CD2 subset 1; CD2-like receptor activating cytotoxic cells; membrane protein FOAP-12; novel LY9 (lymphocyte antigen 9) like protein; protein 19A

BioLegend
mouse monoclonal (162.1)
  • flow cytometry; human; loading ...; fig 4h
In order to detail MAIT cell responses to various microorganisms and cytokines, BioLegend SLAMF7 antibody (BioLegend, 162.1) was used in flow cytometry on human samples (fig 4h). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (162.1)
  • flow cytometry; human; loading ...; fig s14b
In order to map the lineage of human dendritic cells, BioLegend SLAMF7 antibody (BioLegend, 162,1) was used in flow cytometry on human samples (fig s14b). Science (2017) ncbi
mouse monoclonal (162.1)
  • flow cytometry; human; loading ...; fig e6b
  • flow cytometry; mouse; loading ...; fig 3d
In order to investigate the function of SLAMF in phagocytosis of haematopoietic tumour cells, BioLegend SLAMF7 antibody (Biolegend, 162.1) was used in flow cytometry on human samples (fig e6b) and in flow cytometry on mouse samples (fig 3d). Nature (2017) ncbi
mouse monoclonal (162.1)
  • flow cytometry; mouse; loading ...; fig 8a
In order to determine the function of the SLAM family of proteins in natural killer cells, BioLegend SLAMF7 antibody (BioLegend, 162.1) was used in flow cytometry on mouse samples (fig 8a). J Exp Med (2016) ncbi
mouse monoclonal (162.1)
  • flow cytometry; human; loading ...; fig 1d
In order to study the effect of anti-SLAMF6 antibody and ibrutinib on chronic lymphocytic leukemia cells, BioLegend SLAMF7 antibody (biolegend, 162.1) was used in flow cytometry on human samples (fig 1d). Oncotarget (2016) ncbi
mouse monoclonal (162.1)
  • flow cytometry; human; loading ...; fig 2a
In order to screen for and assess myeloma plasma cell markers, BioLegend SLAMF7 antibody (Biolegend, 162.1) was used in flow cytometry on human samples (fig 2a). Blood (2014) ncbi
R&D Systems
rat monoclonal (520914)
  • flow cytometry; mouse; loading ...; fig 1
In order to examine natural killer T cell development in mice deficient for SLAM family receptors, R&D Systems SLAMF7 antibody (R&D Systems, 520914) was used in flow cytometry on mouse samples (fig 1). J Exp Med (2017) ncbi
mouse monoclonal (235614)
  • ELISA; human; 15 ug/ml; loading ...
R&D Systems SLAMF7 antibody (R&D, MAB1906) was used in ELISA on human samples at 15 ug/ml. AAPS J (2016) ncbi
rat monoclonal (520914)
  • flow cytometry; mouse; loading ...; fig 6c
In order to study the effect of anti-SLAMF6 antibody and ibrutinib on chronic lymphocytic leukemia cells, R&D Systems SLAMF7 antibody (R&D, 520914) was used in flow cytometry on mouse samples (fig 6c). Oncotarget (2016) ncbi
mouse monoclonal (235614)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, R&D Systems SLAMF7 antibody (R&D Systems, FAB1906P) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (235614)
  • flow cytometry; human; fig 1c
In order to measure the expression of antigens on malignant human plasma cells that have exhibited promise in targeted cancer therapy, R&D Systems SLAMF7 antibody (R&D Systems, 235614) was used in flow cytometry on human samples (fig 1c). Cytometry B Clin Cytom (2017) ncbi
Invitrogen
mouse monoclonal (162)
In order to identify ABCA1 as a mycobacterial host-restriction factor, Invitrogen SLAMF7 antibody (eBiosciences, 162) was used . Front Microbiol (2016) ncbi
mouse monoclonal (162)
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, Invitrogen SLAMF7 antibody (eBioscience, 162) was used . Cytometry B Clin Cytom (2016) ncbi
Bio-Rad
mouse monoclonal (162)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, Bio-Rad SLAMF7 antibody (ABD SEROTEC, 162) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
Articles Reviewed
  1. Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed publisher
  2. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  3. Chen J, Zhong M, Guo H, Davidson D, Mishel S, Lu Y, et al. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin. Nature. 2017;544:493-497 pubmed publisher
  4. Chen S, Cai C, Li Z, Liu G, Wang Y, Blonska M, et al. Dissection of SAP-dependent and SAP-independent SLAM family signaling in NKT cell development and humoral immunity. J Exp Med. 2017;214:475-489 pubmed publisher
  5. Guo H, Cranert S, Lu Y, Zhong M, Zhang S, Chen J, et al. Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1. J Exp Med. 2016;213:2187-207 pubmed publisher
  6. Long J, Basu Roy R, Zhang Y, Antrobus R, Du Y, Smith D, et al. Plasma Membrane Profiling Reveals Upregulation of ABCA1 by Infected Macrophages Leading to Restriction of Mycobacterial Growth. Front Microbiol. 2016;7:1086 pubmed publisher
  7. Postelnek J, Neely R, Robbins M, Gleason C, Peterson J, Piccoli S. Development and Validation of Electrochemiluminescence Assays to Measure Free and Total sSLAMF7 in Human Serum in the Absence and Presence of Elotuzumab. AAPS J. 2016;18:989-99 pubmed publisher
  8. Yigit B, Halibozek P, Chen S, O Keeffe M, Arnason J, Avigan D, et al. A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells. Oncotarget. 2016;7:26346-60 pubmed publisher
  9. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  10. Lisenko K, Schönland S, Hegenbart U, Wallenwein K, Braun U, Mai E, et al. Potential therapeutic targets in plasma cell disorders: A flow cytometry study. Cytometry B Clin Cytom. 2017;92:145-152 pubmed publisher
  11. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
  12. Frigyesi I, Adolfsson J, Ali M, Christophersen M, Johnsson E, Turesson I, et al. Robust isolation of malignant plasma cells in multiple myeloma. Blood. 2014;123:1336-40 pubmed publisher